D elayeD cerebral ischemia from vasospasm is an important cause of poor outcome after SAH.
Asymptomatic cerebral infarction after SAH is likely to be an under-recognized clinical problem. We performed this study to identify the frequency, risk factors, clinical features, and impact on outcome of clinically asymptomatic infarction due to vasospasm after SAH.
Methods

Study Population
Between July 1, 1996, and May 1, 2002, 580 consecutively admitted patients were prospectively enrolled in the Columbia University SAH Outcomes Project. The study was approved by the Columbia University Medical Center Institutional Review Board, and in all cases written informed consent was obtained from the patient or a surrogate. The diagnosis of SAH was established on the basis of an admission CT scan or by presence of xanthochromia in the cerebrospinal fluid. Patients with secondary SAH related to trauma, rupture of an AVM, or other causes; age < 18 years; or admission > 14 days after SAH onset were excluded from the study.
Definition of DCI
Delayed cerebral ischemia was defined as 1) clinical deterioration (a new focal deficit, decrease in level of consciousness, or both), and/or 2) a new infarct on CT that was not visible on the admission or immediate postoperative scan, when the cause was thought by the research team to be vasosopasm. 5 Other potential causes of clinical deterioration or CT lucencies, such as hydrocephalus, rebleeding, cerebral edema, retraction injury, ventriculitis, metabolic derangements, and seizures, were rigorously ex cluded. Delayed cerebral ischemia and cerebral infarcts due to spasm were diagnosed by the treating study neurointensivist and confirmed in a weekly review of each patient's clinical course by the study team. In each patient with DCI, symptomatic territories were identified, and clinical deficits, angiographic findings, and CT findings were recorded. Evidence of arterial spasm demonstrated by TCD ultrasonography (mean flow velocity > 120 cm/ second) or angiography was used to support the diagnosis but was not mandatory. For the present analysis, patients with DCI were divided into 3 subgroups: 1) neurological deterioration without infarction, 2) neurological deterioration with infarction, and 3) with infarction without corresponding neurological deterioration.
Clinical and Imaging Variables
The calendar day of the index bleeding event was designated SAH Day 0. We recorded baseline demographic data (age and sex), location and size of the aneurysm, angiographic and TCD ultrasonographic findings, and mode of aneurysm treatment (clipping vs coiling). Neurological status on admission was assessed with the Hunt and Hess scale 14 and the GCS. 33 We also evaluated patients' conditions with the Acute Physiology and Chronic Health Evaluation-II (APACHE-II) scale 18 and calculated a physiological subscore by subtracting the GCS score, age, and chronic health elements from the total score. 5 Admission and follow-up CT scans were independently evaluated by a study neurointensivist for the amount and location of subarachnoid blood (SAH sum score, scaled 0 = no blood, 30 = all cisterns and fissures completely filled), 12 intraventricular blood (IVH sum score, scaled 0 = no blood, 12 = all ventricles completely filled), 1 the presence and degree of hydrocephalus, 34 the presence of cerebral edema, 6 and cerebral infarction.
Clinical Management
External ventricular drains were placed in all patients with symptomatic hydrocephalus or IVH with reduced level of consciousness. All patients underwent daily or every-other-day TCD ultrasonography and received oral nimodipine and intravenous hydration with 0.9% saline and 250 ml of 5% albumin solution to maintain a central venous pressure > 5 cm H 2 O. Clinical deterioration due to DCI was treated with HHT to maintain systolic blood pressure between 160 and 220 mm Hg, as required to reverse the neurological deficit. Comatose patients were mechanically ventilated and treated with propofol, fentanyl, or dexmedetomidine to facilitate ventilator synchrony, with interruptions in sedation for clinical assessments at least twice daily. Computed tomography was performed serially when clinically needed. All patients with clinical deterioration underwent CT or MR imaging to identify causes of deterioration other than vasospasm whenever clinically feasible. When clinical evidence of DCI persisted for > 2 hours despite HHT, cerebral angiography was performed to identify vasospasm, and balloon angioplasty or intraarterial administration of verapamil was performed whenever feasible.
Outcome Variables
At 14 days and 3 months after the onset of SAH, each patient or their proxy was asked to complete a 45-minute telephone or in-person interview. Global outcome was assessed with a 7-point version of the mRS, rated from death (6) to symptom-free full recovery (0). 8 Poor outcome was defined as death or moderate-to-severe disability (unable to walk or tend to bodily needs, mRS Score 4-6). In cases in which 3-month mRS scores were not available but the patient was known to be alive, the 14-day mRS score was carried forward. All assessment instruments were administered in the participant's native language (English or Spanish).
Statistical Analysis
Data analyses were performed with commercially available statistical software (SPSS, version 12.0, SPSS Inc.). Admission demographic, clinical, and radiographic variables and therapeutic interventions used during the course of hospitalization were tested for associations with DCI using a univariate analysis of variance for continuous variables and a chi-square test for categorical variables. Significant independent predictors of DCI were identified in binary logistic regression using a forward stepwise selection procedure by identifying significant univariate predictors in 4 blocks: 1) demographic variables, 2) admission clinical variables, 3) admission radiological variables, and 4) diagnostic tests and therapeutic interventions used during hospitalization. A similar analysis was performed among patients with DCI to identify predictors of asymptomatic infarction. To assess the impact of DCI on outcome, we analyzed demographic and admission clinical and radiographic variables and constructed logistic regression models predictive of 1) death, and 2) death or moderate-to-severe disability (mRS Score 4-6). Age, admission Hunt and Hess grade, and aneurysm size were used as covariates. 10 Tests for interactions were performed for all significant variables retained in the baseline multivariate models. Probability values ≤ 0.05 were considered statistically significant.
Results
Study Population
Five hundred seventy six patients were included in the study. Delayed cerebral ischemia was diagnosed in 121, which represents 21% of all patients admitted for SAH. Of these 121 patients, 51 (42%) developed ≥ 1 symptomatic infarcts, 44 (36%) developed symptoms without infarction, and 26 (21%) developed asymptomatic infarction (Figs. 1 and 2).
Vasospasm Diagnosis
A diagnostic angiogram was performed in 533 patients (93%) with 471 (88%) of these studies occurring on or before SAH Day 5. The first diagnostic TCD ultrasonography was performed on or before Day 5 in 303 patients (53%), and 505 patients (88%) had ≥ 1 TCD ultrasonography performed during their hospitalization. The median number of follow-up CT scans was 3 (intraquartile range 2-6). There was no difference in the frequency of early angiographic or TCD ultrasonography-documented vasospasm in the symptomatic and asymptomatic DCI groups (Table 1) . However, among those in whom an infarct developed, asymptomatic patients less often had TCD ultrasonographic evidence of vasospasm over the course of their hospitalization (any velocity > 120 cm/ second, 56 vs 78%, p = 0.01) and had fewer vessels in spasm at the time of follow-up angiography (mean ± SD, 1.5 ± 2.2 vs 2.8 ± 2.7, p = 0.03).
Predictors of DCI
Compared with patients without DCI, patients in whom DCI developed had worse Hunt and Hess (p < 0.001) and GCS (p < 0.001) scores, were more likely to have sentinel headaches preceding hemorrhage (p = 0.045) or lose consciousness at ictus (p = 0.02), and had higher SAH (p = 0.007) and IVH sum (p < 0.018) scores on admission CT. Patients in whom DCI was diagnosed were also more likely to have angiographic vasospasm (p < 0.001) or a TCD mean velocity > 120 cm/second (p < 0.001) on or before SAH Day 5. Multivariable logistic regression revealed GCS score < Fig. 1 . Flow diagram. In 35 patients (6% of the total cohort) the 14-day mRS score was carried forward because a 3-month score was not available.
15 (adjusted OR 2.6, 95% CI 1.5-4.7, p < 0.001) and angiographic spasm detected on or before SAH Day 5 (adjusted OR 2.6, 95% CI 1.5-4.6, p < .001) as significant predictors of DCI.
Admission Predictors of Asymptomatic Infarction From Vasospasm
In a univariate analysis, patients with asymptomatic infarction did not differ significantly from patients with symptomatic DCI with regard to age, sex, ethnicity, aneurysm characteristics, or treatment modality (Table 1) . However, patients with asymptomatic DCI more often had poor clinical status on admission (Hunt and Hess and GCS scores), were more likely to lose consciousness at ictus, had more IVH and less SAH than patients with symptomatic DCI, and were more likely to undergo EVD placement (Table 1) . Multivariable binary logistic regression revealed that patients with asymptomatic DCI were more likely to be comatose (GCS Score 3-8, adjusted OR 7.9, 95% CI 2.0-31.6, p = 0.004), undergo ventricular drainage (adjusted OR 3.8, 95% CI 1.1-13.0, p = 0.03), and have a median SAH sum score ≤ 15 (adjusted OR 0.1, 95% CI 0.02-0.4, p = 0.001) than patients with symptomatic DCI.
Hospital Course
Patients with asymptomatic DCI were less likely to be treated with vasopressors than patients with symptomatic DCI (Table 1 ). There were no significant differences in the anatomical distribution of asymptomatic and symptomatic infarctions (see Table 2 ), or in the proportion of patients with multiple infarcts.
Asymptomatic DCI and Outcome
Forty-six percent of patients with asymptomatic DCI were dead at 3 months compared with 20% of those with symptomatic DCI (adjusted OR 2.5, 95% CI 0.9-7.1, p = 0.07). Seventy-three percent of asymptomatic DCI patients were dead or moderately-to-severely disabled (mRS Score 4-6) at 3 months compared with 40% of those with symptomatic DCI (adjusted OR 3.9, 95% CI 1.3-12.0, p = 0.017). Among patients without DCI, 19% (82/441) were dead and 31% (137/441) dead or moderately-to-severely disabled (mRS Score 4-6). Compared with patients without DCI, pa tients with asymptomatic DCI and infarction had a significantly greater risk of death or moderate-to-severe disability (mRS Score 4-6) at 3 months, whereas patients with symptomatic DCI did not (Table 3) .
Discussion
The diagnosis and treatment of symptomatic DCI due to vasospasm is an important goal of the intensive care management of SAH. Although prior reports have made the observation that vasospasm can sometimes cause brain infarction without neurological deterioration, 17, 30 this phenomenon has received little attention to date. In this singlecenter prospective cohort study, we found that ~ 20% of cases of DCI were related to clinically asymptomatic or Cardiopulmonary resuscitation was performed in the field and the patient had several generalized tonic-clonic seizures in the emergency department. Angiography revealed a right posterior inferior cerebellar artery aneurysm, which was treated with coil placement. An echocardiogram showed global hypokinesis and a reduced ejection fraction, and a pulmonary artery catheter was placed for volume management. Follow-up CT showed a new asymptomatic left posterior frontal infarct attributed to vasospasm. At 3 weeks after SAH the patient recovered the ability to follow commands. At 12 months' follow-up he was not able to carry out all previous activities, but he could look after his own affairs without assistance (mRS Score 2). B: Scan obtained in a 39-year-old man classified as Hunt and Hess Grade IV. Angiography showed a left vertebral artery dissection with pseudoaneurysm formation, which was treated endovascularly. New bilateral cerebellar infarcts appeared on follow-up CT on SAH Day 4, and angiography showed diffuse severe anterior and posterior circulation vasospasm. Despite balloon angioplasty of both circulations and treatment with induced hypertension, the patient's condition deteriorated due to symptomatic bilateral MCA territory infarction. Life support was withdrawn on SAH Day 9. C: Scan obtained in a 60-year-old man showing Hunt and Hess Grade V with decorticate posturing and extensive intraventricular hemorrhage. Angiography showed a left pericallosal artery AVM with a 5-mm feeding artery aneurysm, which was treated with coil placement. A TCD ultrasonographic study on SAH Day 8 showed accelerated flow velocities in the anterior and middle cerebral arteries bilaterally, and CT showed new bilateral anterior cerebral artery territory infarcts on the same day without a notable change in findings on clinical examination. The patient subsequently developed neurogenic fever and central hyperventilation. Because he showed no evidence of neurological improvement, life support was withdrawn on SAH Day 15. Postmortem examination confirmed the presence of anterior cerebral artery vasospasm in the region of the AVM, diffuse periventricular heme-related necrosis, and infarction involving the territory of the pericallosal arteries bilaterally.
"silent" cerebral infarction, without symptoms that might have triggered a therapeutic intervention. Patients with DCI who did not experience obvious clinical deterioration were significantly less likely to receive vasopressor therapy than symptomatic patients, and were more likely to be dead or severely disabled at 3 months after SAH, even after accounting for established baseline predictors of poor outcome. These findings indicate that clinically asymptomatic DCI is a relatively common, clinically important, and under-treated problem. Strategies directed at diagnosing or preventing asymptomatic infarction due to vasospasm in poor-grade SAH patients are needed.
Overall, 21% of our patients developed DCI, which is at the low end of the range of 20-50% reported in other large case series. 4 ,5,12,13,19,21, 23 The relatively low frequency of DCI in our cohort might reflect our intensive care unit management strategy, but is more likely the result of our stringent algorithm for diagnosing clinical deterioration or infarction from vasospasm, which relies on a comprehensive review and adjudication of all clinical events and imaging studies near the end of each patient's hospitalization. Of the 77 patients who experienced infarction due to vasospasm, 26 (34%) were asymptomatic, which is higher than the 11% frequency reported in a careful analysis of SAH infarct topography by Rabinstein et al.
24
Few studies have specifically analyzed the problem of asymptomatic infarction due to vasospasm after SAH. Shimoda et al. 30 performed serial postoperative MR imaging in 125 patients with SAH and found a much higher frequency of DCI due to vasospasm than we found in our † Probability values refer to comparison of asymptomatic patients with infarction to symptomatic DCI patients with or without infarction.
‡ Statistically significant (p � 0.05). § Scaled from 0 to 30; 0 = no blood, 30 = all cisterns and fissures completely filled with blood. || On or before SAH Day 5.
CT-based study (61 vs 21%), despite a similar distribution of clinical grades. This discrepancy can be explained by the superior sensitivity of MR imaging for detecting subtle ischemic changes. 2, 25, 32, 36 Approximately one-third of DCI episodes in the study by Shimoda et al. 30 were characterized by detection of a new asymptomatic ischemic lesion with MR imaging. Interestingly, the overall frequency of CT-detected asymptomatic infarction in their study was 6%, which is nearly identical to the 5% frequency that we found. Thus, routine MR imaging is likely to reveal a substantially higher frequency of asymptomatic DCI than we found in our study.
In a smaller report of 39 poor-grade SAH cases (Hunt and Hess Grades III-V), Kirmani et al. 17 reported CTdocumented infarction from vasospasm in 51%; the infarct was asymptomatic in over one-third of cases. Patients with silent infarction had worse Glasgow Outcome Scale scores at 1 month compared with those without in farction. We found similarly that among those with DCI, asymptomatic patients had worse outcomes than those with symptomatic ischemia, even after adjustment for age, clinical grade, and aneurysm size. These findings in dicate that infarcts from vasospasm can hamper neurological recovery after SAH even when they develop in the absence of symptoms.
We found that among all DCI patients, risk factors for asymptomatic infarction included coma on admission, EVD placement (almost always reflecting the presence of IVH), and paradoxically, smaller amounts of subarachnoid blood in the basal cisterns. The association of coma with asymptomatic infarction most likely reflects limited sensitivity of the clinical examination, and possibly the use of sedation to facilitate mechanical ventilation. By contrast, Shimoda et al. 30 found that symptomatic infarction was associated with poor clinical grade, which might reflect the greater sensitivity of MR imaging for detecting subtle lesions in poor-grade cases. They also found that symptomatic infarction was associated with older age, angiographic vasospasm, hydrocephalus, and multiple or bilateral infarcts. 30 Intraventricular hemorrhage has been identified as a risk factor for the development of DCI in addition to thick cisternal clot, 5, 11 and EVD placement has been identified as a risk factor for multifocal infarction from vasospasm. 24 The association of EVD placement and smaller amounts of cisternal SAH with silent infarction in our study might be explained by a tendency for thick cisternal clot to produce large-vessel spasm and symptomatic DCI, and IVH to produce microcirculatory or autoregulatory disturbances and asymptomatic ischemia. 5 This hypothesis is supported by the fact that among patients with DCI and infarction in our study, asymptomatic patients had less angiographic and TCD ultrasonographic evidence of vasospasm than those with symptoms.
Shimoda et al. 30 reported that asymptomatic infarcts preferentially developed in noneloquent perforating vessel regions such as the claustrum and putamen. In our analysis, the involved vascular territories did not differ significantly between patients with symptomatic and silent infarction. Most infarcts involved cortical as opposed to penetrating vessel territories, and the frequency or territorial and watershed distribution was the same regardless of whether the infarcts were symptomatic (Table 2) . Our findings do not support the notion that asymptomatic infarction after SAH is explained by a tendency to occur in noneloquent brain regions.
Our analysis has limitations. The generalizability of our findings is limited by the single-center design of this study. We did not perform MR imaging, and the CT scans that we did perform were not obtained according to a uniform protocol. Thus our study provides no information on ischemic injury beyond the resolution of CT, and we may have failed to detect some cases of CT-detectable silent infarction, particularly in poor-grade cases in which aggressive support was withdrawn early. The clinical diagnosis of symptomatic vasospasm is always subjective to some degree, a fact that we dealt with by adjudicating this outcome among the entire research team. A larger study cohort or more complete follow-up at 3 months may have increased our ability to identify additional predictors of asymptomatic infarction. The unfavorable impact of clinically silent infarction after SAH on long-term outcome calls for more intense and vigilant monitoring for secondary ischemic injury, particularly in poor-grade cases. Intensive multimodal neuromonitoring of brain tissue oxygen tension (PbtO 2 ), cerebral microdialysis, and continuous electroencephalography may be adjuncts to the clinical examination and have been shown to identify patients at increased risk for DCI or herald the onset of ischemic injury in comatose patients. 3, 7, 28 Loss of autoregulatory capacity can be detected with brain tissue oxygen monitoring and has been linked to an increased risk of DCI after SAH. 15 Brain tissue oxygen tension desaturations have also been linked to poor outcome after SAH. 15 Increased lactate/pyruvate ratios and glutamate levels occur with ischemic injury after SAH and have been associated with DCI and poor outcome, 26, 27, 31 and changes in alpha variability and the alpha/delta ratio on signal-processed electroencephalograms have been shown to predict symptomatic vasospasm. 7, 35 Magnetic resonance imaging has superior sensitivity for detecting subtle ischemic changes after SAH compared with CT, 30 and perfusion and diffusion weighted imaging have been shown to be promising modalities for detecting widespread changes in tissue hemodynamics surrounding early ischemic lesions. 25 Further research is needed to investigate whether outcome after poor-grade SAH can be improved by linking these monitoring strategies to aggressive strategies that improve cerebral perfusion and prevent infarction.
Finally, as progress continues to be made in linking neuromonitoring to innovative therapeutic strategies after SAH, we believe that our findings have implications for routine management. In light of the fact that a substantial amount of ischemic injury after SAH may go undetected in patients with poor-grade SAH, we routinely perform surveillance angiography between Days 4 and 8 after onset, with the timing of these investigations dictated by the development of TCD ultrasonographic and CT perfusion abnormalities, and we prophylactically treat vasospasm with intraarterial vasodilators or balloon angioplasty. Others have advocated the routine use of prophylactic HHT in all patients with SAH at high risk for developing DCI. 22 Clinical trials are needed to evaluate these management strategies and determine whether they can reduce the frequency of infarction and improve outcome after SAH.
Conclusions
Clinically asymptomatic brain infarction due to vasospasm represents 20% of all cases of DCI, occurs primarily in patients with depressed level of consciousness, tends to go untreated, and has a negative impact on outcome. Invasive neuromonitoring and other strategies directed at diagnosing and preventing asymptomatic infarction due to vasospasm in poor-grade SAH cases are needed.
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